Home › Funds › NIA IMPACT ADVISORS, LLC › IBRX
NIA IMPACT ADVISORS, LLC position in IBRX
IMMUNITYBIO INC · Health Care
NIA IMPACT ADVISORS, LLC reported holding 235,907 shares of IBRX (IMMUNITYBIO INC) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 0.96% of its reported portfolio and ranking #43 among its reported holdings. NIA IMPACT ADVISORS, LLC has disclosed IBRX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR
How NIA IMPACT ADVISORS, LLC's IBRX position evolved
NIA IMPACT ADVISORS, LLC first disclosed a stake in IBRX in Q1 2026 at 268,797 shares (US$2.1M). The position peaked in Q2 2026 at 270,167 shares, worth US$2.4M. Across 3 filings, NIA IMPACT ADVISORS, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 235,907 shares valued at US$2.2M — a reduction of -34,260 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 268.80K | $2.06M | New |
| Q2 2026 | 270.17K | $2.37M | Add |
| Q3 2026 | 235.91K | $2.23M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IBRX and 13F data
IBRX (IMMUNITYBIO INC) is a Health Care company. 68 other funds we track also report a position in IBRX — the largest reported positions include GREAT POINT PARTNERS LLC (US$26.3M), VESTOR CAPITAL, LLC (US$12.1M), Sound Capital Solutions LLC (US$9.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IBRX
- GREAT POINT PARTNERS LLC 3.00M sh · $26.27M · Q2 2026
- VESTOR CAPITAL, LLC 44.84K sh · $12.05M · Q2 2026
- Sound Capital Solutions LLC 1.12M sh · $9.81M · Q2 2026
- Clearwater Capital Advisors, LLC 717.52K sh · $6.28M · Q2 2026
- ALLEN HOLDING INC /NY 687.57K sh · $6.02M · Q2 2026
- Kercheville Advisors, LLC 613.38K sh · $5.79M · Q3 2026
- SHEETS SMITH WEALTH MANAGEMENT 512.57K sh · $4.84M · Q3 2026
- Legacy Capital Group California, Inc. 446.00K sh · $3.90M · Q2 2026
- MOR Wealth Management, LLC 302.45K sh · $2.65M · Q2 2026
More on NIA IMPACT ADVISORS, LLC
FAQ
How long has NIA IMPACT ADVISORS, LLC held IBRX?
NIA IMPACT ADVISORS, LLC has disclosed IBRX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is NIA IMPACT ADVISORS, LLC's current position in IBRX?
As of Q3 2026, NIA IMPACT ADVISORS, LLC holds 235.91K shares of IBRX (IMMUNITYBIO INC), valued at $2.23M, representing 0.96% of its reported portfolio and ranking #43.
Has NIA IMPACT ADVISORS, LLC been buying or selling IBRX?
In the latest 13F filing (Q3 2026), NIA IMPACT ADVISORS, LLC reduced its position in IBRX. The position peaked in Q2 2026 at 270.17K shares.
Which other funds hold IBRX?
Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, VESTOR CAPITAL, LLC, Sound Capital Solutions LLC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.